{"title":"具有静态和旋转调强放疗中基于远程电子门静脉成像设备的剂量学审计经验。","authors":"Peter B Greer, Joerg Lehmann, Alisha Moore","doi":"10.1016/j.phro.2024.100674","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this work was to evaluate results of a remote electronic portal imaging based dosimetric auditing method using Task-Group 218 clinical gamma evaluation criteria (3%,2 mm, 10% dose threshold). For intensity modulated radiation therapy the results were (mean ± 1 SD) 97.9 ± 4.5% with 31/34 audits passing (optimal level, <math><mo>≥</mo></math> 95%) and 3/34 audits failing (action level, <math><mo><</mo></math> 90%). For volumetric modulated arc therapy the results were 98.5 ± 2.3% with 32/36 audits passing (optimal level) and 4/36 passing (tolerance level, <math><mo>≥</mo></math> 90% and <math><mo><</mo></math> 95%). The audit has been successfully applied globally for clinical trial quality assurance.</p>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"32 ","pages":"100674"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663962/pdf/","citationCount":"0","resultStr":"{\"title\":\"Experience with remote electronic portal imaging device-based dosimetric auditing for static and rotational intensity modulated radiotherapy.\",\"authors\":\"Peter B Greer, Joerg Lehmann, Alisha Moore\",\"doi\":\"10.1016/j.phro.2024.100674\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The aim of this work was to evaluate results of a remote electronic portal imaging based dosimetric auditing method using Task-Group 218 clinical gamma evaluation criteria (3%,2 mm, 10% dose threshold). For intensity modulated radiation therapy the results were (mean ± 1 SD) 97.9 ± 4.5% with 31/34 audits passing (optimal level, <math><mo>≥</mo></math> 95%) and 3/34 audits failing (action level, <math><mo><</mo></math> 90%). For volumetric modulated arc therapy the results were 98.5 ± 2.3% with 32/36 audits passing (optimal level) and 4/36 passing (tolerance level, <math><mo>≥</mo></math> 90% and <math><mo><</mo></math> 95%). The audit has been successfully applied globally for clinical trial quality assurance.</p>\",\"PeriodicalId\":36850,\"journal\":{\"name\":\"Physics and Imaging in Radiation Oncology\",\"volume\":\"32 \",\"pages\":\"100674\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663962/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physics and Imaging in Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.phro.2024.100674\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phro.2024.100674","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Experience with remote electronic portal imaging device-based dosimetric auditing for static and rotational intensity modulated radiotherapy.
The aim of this work was to evaluate results of a remote electronic portal imaging based dosimetric auditing method using Task-Group 218 clinical gamma evaluation criteria (3%,2 mm, 10% dose threshold). For intensity modulated radiation therapy the results were (mean ± 1 SD) 97.9 ± 4.5% with 31/34 audits passing (optimal level, 95%) and 3/34 audits failing (action level, 90%). For volumetric modulated arc therapy the results were 98.5 ± 2.3% with 32/36 audits passing (optimal level) and 4/36 passing (tolerance level, 90% and 95%). The audit has been successfully applied globally for clinical trial quality assurance.